EUVIMEDEUVIMED entdecken
Open Access

Therapeutic Potential of Heat Shock Protein 90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment

Soo Min Lee, Myoung Seok Lee iD, Hae Rim Jung iD, Jeonghwan Lee, Bogyeong Cho, Wencheng Jin iD, Min Hoan Moon iD, Nayeon Shin iD, Seung Hyun Han iD, Da Som Choi, Bada Lee, Seung-Pyo Hong und 5 weitere

Journal of the American Society of Nephrology · 2026-07 · 37 (7) · 1404-1422

DOI: 10.1681/asn.0000000975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 26.01.2026. Verfasst von Soo Min Lee und 16 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Benzoquinones, Lactams, Macrocyclic, HSP90 Heat-Shock Proteins, Methyltransferases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Targeting METTL3 with the heat shock protein 90 inhibitor 17-DMAG mitigated kidney fibrosis in CKD. The drug repositioning through differentially expressed gene and enrichment analyses identified 17-dimethylaminoethylamino-17-demethoxygeldanamycin as a potential agent to alleviate kidney fibrosis. The N -terminal heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin suppressed c-Jun–METTL3 signaling, attenuating N 6-methyladenosine methylation and kidney fibrosis.

Background

Kidney fibrosis is a major pathological feature of CKD, characterized by excessive deposition of extracellular matrix proteins, leading to progressive loss of kidney function. N 6-methyladenosine (m6A) RNA methylation has emerged as a crucial epigenetic modification implicated in various diseases, including kidney fibrosis. METTL3, an m6A writer, plays a key role in promoting fibrosis by stabilizing profibrotic gene expression. Therefore, targeting METTL3 represents a promising therapeutic strategy for CKD treatment. In this study, we explored the therapeutic potential of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in regulating METTL3 to mitigate kidney fibrosis.

Methods

Through transcriptome-based drug repositioning, we identified 17-DMAG as a potential inhibitor of METTL3. Differentially expressed gene analysis was performed to assess the enrichment of 17-DMAG in CKD-related gene expression profiles. The antifibrotic effects of 17-DMAG were evaluated in in vitro and in vivo models. The mechanism by which 17-DMAG downregulates METTL3 was also investigated.

Results

17-DMAG significantly reduced METTL3 expression in renal epithelial cells in a dose-dependent and time-dependent manner. In in vivo mouse models of kidney fibrosis, 17-DMAG treatment attenuated METTL3 levels, reduced total m6A modification, and effectively mitigated fibrosis, as evidenced by decreased collagen deposition and profibrotic marker expression. Mechanistically, 17-DMAG, a heat shock protein 90 (HSP90) N -terminal inhibitor, induced a heat shock response that sequentially upregulated HSP70 expression. The elevated HSP70 levels inhibited c-Jun N -terminal kinase activity, thereby suppressing the c-Jun transcription factor and ultimately leading to the downregulation of METTL3 expression. MeRIP-Seq analysis revealed that 17-DMAG reversed unilateral ischemia-reperfusion injury–induced m6A epitranscriptomic changes in fibrosis-related genes, including GSK3B , which is involved in fibrotic pathways.

Conclusions

N -terminal HSP90 inhibition, along with subsequent c-Jun suppression, contributed to the mechanism underlying 17-DMAG–induced METTL3 downregulation. Through this regulatory pathway, 17-DMAG effectively suppressed METTL3 expression and attenuated kidney fibrosis in both in vitro and in vivo models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoquinonesLactams, MacrocyclicHSP90 Heat-Shock ProteinsMethyltransferasesKidneyRenal Insufficiency, ChronicAnimalsFibrosisMiceMaleRNA MethylationSignal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

CKDfibrosisgene expressionimagingischemia-reperfusionkidneyobstructive nephropathypharmacologyrenal fibrosis

Substanzen

BenzoquinonesLactams, Macrocyclic17-(dimethylaminoethylamino)-17-demethoxygeldanamycinHSP90 Heat-Shock ProteinsMethyltransferasesMettl3 protein, mouse

Autor:innen und Institutionen

  • College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.
  • Department of Radiology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Myoung Seok Lee, Hae Rim Jung, Wencheng Jin, Min Hoan Moon, Nayeon Shin, Seung Hyun Han, Chun Soo Lim, Sung-Yup Cho, Jung Pyo Lee

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Lee, S. M., Lee, M. S., Jung, H. R., Lee, J., Cho, B., Jin, W., Moon, M. H., Shin, N., Han, S. H., Choi, D. S., Lee, B., Hong, S. P., Kim, J. I., Lim, C. S., Cho, S. Y., Choi, J. W., & Lee, J. P. (2026). Therapeutic Potential of Heat Shock Protein 90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment. Journal of the American Society of Nephrology, 37(7), 1404-1422. https://doi.org/10.1681/asn.0000000975

Vancouver

Lee SM, Lee MS, Jung HR, Lee J, Cho B, Jin W, et al. Therapeutic Potential of Heat Shock Protein 90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment. Journal of the American Society of Nephrology. 2026;37(7):1404-1422. doi:10.1681/asn.0000000975

BibTeX
@article{Lee2026,
  author = {Lee, Soo Min and Lee, Myoung Seok and Jung, Hae Rim and Lee, Jeonghwan and Cho, Bogyeong and Jin, Wencheng and Moon, Min Hoan and Shin, Nayeon and Han, Seung Hyun and Choi, Da Som and Lee, Bada and Hong, Seung-Pyo and Kim, Jong-Il and Lim, Chun Soo and Cho, Sung-Yup and Choi, Jin Woo and Lee, Jung Pyo},
  title = {Therapeutic Potential of Heat Shock Protein 90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {7},
  pages = {1404--1422},
  doi = {10.1681/asn.0000000975}
}
Kostenlos starten →